Asia Green Biotechnology

Asia Green Biotechnology EBITDA

Delisted·Sep 23, 2026

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Asia Green Biotechnology (ASIA.CN) as of Nov 15, 2026 is -169,082.00 CAD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -179,206.00 CAD — a change of -5.65% (higher).

EBITDA

-169,082.00CAD

YoY

-5.65%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Asia Green Biotechnology is 2023 -169,082.00 CAD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Asia Green Biotechnology was 2022 -179,206.00 CAD. It decreases by -5.65% higher compared to the previous year.

The Asia Green Biotechnology EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-916,603.00 CAD
Jan 1, 2019
-727,180.00 CAD
Jan 1, 2020
-552,833.00 CAD
Jan 1, 2021
-523,235.00 CAD
Jan 1, 2022
-179,206.00 CAD
Jan 1, 2023
-169,082.00 CAD
The Asia Green Biotechnology EBITDA history
YEAREBITDAYoY
-169,082.00CAD-5.65%
-179,206.00CAD-65.75%
-523,235.00CAD-5.35%
-552,833.00CAD-23.98%
-727,180.00CAD-20.67%
-916,603.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Asia Green Biotechnology Stock analysis

What does Asia Green Biotechnology do? Asia Green Biotechnology Corp develops and supplies proprietary organic hybridization technology for agri-technology applications. The company partners with InPlanta Biotechnology Inc. for hemp cultivation under a license agreement, and collaborates with Swysh Inc. and Pathway Rx Corp for cannabinoid extract development. Revenue is generated through the supply of technology and related products, with operations expanding in Cambodia and Thailand through R&D programs. The firm focuses on commercial hemp and cannabinoid product development under licensed agreements. The company's primary market segments include agricultural technology providers and medicinal cannabinoid extract buyers. InPlanta Biotechnology Inc. licenses hemp cultivation, while Swysh Inc. and Pathway Rx Corp. license cannabinoid extract development. Asia Green Biotechnology Corp. supplies technology and manages the commercialization of these products derived from its organic hybridization technology. Asia Green Biotechnology Corp. operates under license agreements with InPlanta Biotechnology Inc., Swysh Inc., and Pathway Rx Corp. to develop and supply hemp and cannabinoid products. The company's revenue streams come from technology supply and product commercialization under these agreements, with R&D programs in Cambodia and Thailand supporting future market expansion. Asia Green Biotechnology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Asia Green Biotechnology stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Asia Green Biotechnology is -169,082.00 CAD in 2023.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Asia Green Biotechnology changed from -179,206.00 CAD to -169,082.00 CAD, representing a -5.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Asia Green Biotechnology since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Asia Green Biotechnology historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Asia Green Biotechnology

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Asia Green Biotechnology